Full name
STORKPHARM INVESTMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of medicines and other pharmaceutical products
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade, except of motor vehicles and motorcycles
49.41.Z - Freight transport by road
52 - Warehousing and support activities for transportation
64.19.Z - Other monetary intermediation
72 - Scientific research and development
82 - Office administrative, office support and other business support activities
96.09.Z - Other personal service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | -0,5 | -0,1 | 84,1 |
EBITDA | -0,2 | 0,1 | 185,2 | |
Short time liabilities | 0 | 0,1 | 133,6 | |
Income tax | 0 | -100 | ||
Equity capital | 0 | -0,5 | -0,6 | -16,4 |
Operating profit (EBIT) | -0,2 | 0,1 | 185,2 | |
Assets | 4 | 4,5 | 4,5 | 0,5 |
Net profit (loss) | 0 | -0,5 | -0,1 | 84,1 |
Cash | 0 | 0 | -18,2 | |
Net income from sale | 0 | 0,2 | 425,2 | |
Liabilities and provisions for liabilities | 4 | 5 | 5,1 | 2 |
Working assets | 3,9 | 4,4 | 4,4 | 0,5 |
Depreciation | 0 | 0 | 0 | |
Basic operational activity income | 0,1 | 342,8 | ||
% | % | % | p.p. | |
Profitability of capital | 32,6 | 103,4 | 14,1 | -89,3 |
Equity capital to total assets | 0,4 | -10,9 | -12,6 | -1,7 |
Gross profit margin | 10,1 | -1558 | -47,1 | 1510,9 |
EBITDA Margin | -528,8 | 85,8 | 614,6 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 249 | 111 | -138 | |
Current financial liquidity indicator | 2.3392386436462402 | 2.313976764678955 | 0 | |
Net dept to EBITDA | -17.9234561920166 | 21.561065673828125 | 39,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane